Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH vs IGF-I Monitoring for Acromegaly
NCT01618513Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Jun 2012
- Primary completion
- Jan 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Octreotide long-acting injection in acromegaly, sponsored by Aarhus University. Started Jun 2012; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT01618513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01618513.